Related Experiment Video

Updated: Jun 3, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

Sudden cardiac death risk stratification in patients with heart failure

Peem Lorvidhaya1, Kamel Addo, Adam Chodosh

  • 1Division of Cardiology, Rhode Island and Miriam Hospitals, The Warren Alpert Medical School of Brown University, 2 Dudley Street, Suite 360, Providence, RI 02905, USA.

Heart Failure Clinics
|March 29, 2011
PubMed

Insights

Identifying the causes of arrhythmias in heart failure patients is crucial for accurate risk stratification. Current methods lack the specificity to identify patients at risk for sudden cardiac death.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Medical Research

Background:

  • Heart failure patients face a high risk of developing arrhythmias.
  • Multiple underlying mechanisms contribute to arrhythmogenesis in heart failure.
  • Effective risk stratification for sudden cardiac death is currently limited.

Purpose of the Study:

  • To review the current knowledge on risk stratification for sudden cardiac death in heart failure.
  • To highlight the need for mechanism-specific diagnostic tests.
  • To address limitations in existing risk stratification strategies.

Main Methods:

  • Literature review of current studies on heart failure and sudden cardiac death risk stratification.
  • Analysis of existing diagnostic approaches and their relation to arrhythmogenic mechanisms.
  • Identification of knowledge gaps and limitations in current research.

Main Results:

  • The diversity of arrhythmogenic mechanisms in heart failure complicates risk stratification.
  • Current risk stratification efforts are often neither cost-effective nor accurate due to a lack of mechanism-specific tests.
  • Significant limitations exist within the current body of research on this topic.

Conclusions:

  • Developing tests to identify specific arrhythmogenic substrates is essential for improved risk stratification.
  • Accurate identification of patients at risk for sudden cardiac death requires a deeper understanding of underlying mechanisms.
  • Future research should focus on mechanism-based diagnostic tools for heart failure patients.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...